These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 740299)

  • 1. [New demands in the epidemiological control by chemical antibiotics].
    Vanini GC; Grassi R
    Minerva Med; 1978 Dec; 69(59):4029-36. PubMed ID: 740299
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibiotics of the phosphonic acid group].
    Poliak MS
    Antibiot Med Biotekhnol; 1987 Jan; 32(1):66-75. PubMed ID: 3551820
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bacteriological aspects of chemoantibiotic therapy with fosfomycin].
    Lamanna A; Nicoletti P
    Minerva Med; 1978 Dec; 69(59):4061-6. PubMed ID: 740301
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiments in the use of fosfomycin in oral microbial infections].
    Quaranta M
    Dent Cadmos; 1983 Mar; 51(3):57-64. PubMed ID: 6576933
    [No Abstract]   [Full Text] [Related]  

  • 5. A multicenter, randomized parallel double-blind study comparing three antibiotics, cephemic-cofosfolactamine, fosfomycin and cephalexin, in the treatment of systemic infections.
    Mangini P; Cicchetti M; Bottaro L; Messina V; Brancadoro MT; Puppo F
    Chemioterapia; 1985 Jun; 4(3):222-6. PubMed ID: 4028283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fosfomycin in severe infection in neonatology].
    Rossignol S; Regnier C
    Ann Pediatr (Paris); 1984 May; 31(5):437-44. PubMed ID: 6742722
    [No Abstract]   [Full Text] [Related]  

  • 7. [The behavior of Staphylococcus aureus responsible for hospital infections in the presence of phosphomycin activity in vitro].
    Mendonca CP; Lourenço VL; Shimizu MT; Natalino PR; Anno IS
    Rev Saude Publica; 1975 Mar; 9(1):11-4. PubMed ID: 1145089
    [No Abstract]   [Full Text] [Related]  

  • 8. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics.
    Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J
    Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria (author's transl)].
    Zemelman R; González C; Mondaca MA
    Rev Med Chil; 1980 Dec; 108(12):1112-7. PubMed ID: 7302408
    [No Abstract]   [Full Text] [Related]  

  • 10. Reevaluation of fosfomycin: clinical and laboratory studies.
    Dai ZY; Zhang YY; Zhang MF; Zhang ZL; Zhang JD; Liu YK
    Chin Med J (Engl); 1981 Oct; 94(10):645-52. PubMed ID: 6797798
    [No Abstract]   [Full Text] [Related]  

  • 11. Chromosomal localization of resistance to fosfomycin and aminocyclitol antibiotics in hospital strains of Staphylococcus aureus.
    Młynarczyk A; Młynarczyk G; Bardowski J; Osowiecki H
    Acta Microbiol Pol; 1985; 34(2):145-54. PubMed ID: 2412402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
    Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
    Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspects of immune response induced by bacteria treated with subinhibiting doses of fosfomycin].
    Viano I; Martinetto P; Valtz A; Santiano M; Barbaro S
    G Ital Chemioter; 1979; 26(1-2):281-4. PubMed ID: 400141
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibacterial activity of fosmidomycin on chromosomic and plasmid-determined fosfomycin-resistant strains.
    Mendez FJ; Alvarez AA; Mendoza MC; Hardisson C
    Chemioterapia; 1985 Apr; 4(2):170-5. PubMed ID: 4006006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of quinolone-resistant Enterobacteriaceae uropathogens to fosfomycin trometamol, in Dakar, Senegal.
    Nabeth P; Perrier-Gros-Claude JD; Juergens-Behr A; Dromigny JA
    Scand J Infect Dis; 2005; 37(6-7):497-9. PubMed ID: 16012011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fosfomycin resistance in Staphylococcus saprophyticus and other species of coagulase-negative staphylococci].
    Loulergue J; Pinon G; Laudat P; Audurier A
    Ann Microbiol (Paris); 1984; 135A(2):239-47. PubMed ID: 6721325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appearance of fosfomycin resistant Rahnella aquatilis clinically isolated in Japan.
    O'Hara K; Chen J; Shigenobu F; Nakamura A; Taniguchi K; Shimojima M; Ida H; Yoshikawa E; Tsuboi I; Mizuoka K; Sawai T
    Microbios; 1998; 95(381):109-15. PubMed ID: 9872000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study and use of fosfomycin in the clinical field].
    Azzaroli P; de Martinis E; Zoli F; Garoia C
    G Ital Chemioter; 1978; 25(1):1-4. PubMed ID: 376386
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo interaction of cis-platinum and fosfomycin on squamous cell carcinoma.
    Tandy JR; Tandy RD; Farris P; Truelson JM
    Laryngoscope; 2000 Jul; 110(7):1222-4. PubMed ID: 10892700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.